Table 2.
Comparative analysis between results of the proposed method and other studies using 5-fold cross-validation
| Dataset | Model | ACC (%) | SN (%) | SP (%) | MCC | Method |
|---|---|---|---|---|---|---|
| H_990 | iRNA-PseU | 60.40 | 61.01 | 59.80 | 0.21 | Chen et al., 2016 |
| PseUI | 64.24 | 64.85 | 63.64 | 0.28 | He et al., 2018 | |
| iPseU-CNN | 66.68 | 65.00 | 68.78 | 0.34 | Tahir et al., 2019 | |
| iPseU-NCP | 62.92 | 58.79 | 65.05 | 0.24 | Ours | |
| S_628 | iRNA-PseU | 64.49 | 64.65 | 64.33 | 0.29 | Chen et al., 2016 |
| PseUI | 65.13 | 62.74 | 67.52 | 0.30 | He et al., 2018 | |
| iPseU-CNN | 68.15 | 66.36 | 70.45 | 0.37 | Tahir et al., 2019 | |
| iPseU-NCP | 69.59 | 77.07 | 62.10 | 0.40 | Ours | |
| M_944 | iRNA-PseU | 69.07 | 73.31 | 64.83 | 0.38 | Chen et al., 2016 |
| PseUI | 70.44 | 79.87 | 70.34 | 0.41 | He et al., 2018 | |
| iPseU-CNN | 71.81 | 74.79 | 69.11 | 0.44 | Tahir et al., 2019 | |
| iPseU-NCP | 71.82 | 67.37 | 76.27 | 0.44 | Ours |
Values which are significantly higher than the others are in bold. Data excerpted from [16]